SARS-CoV-2-IN-45

• Description :

  SARS-CoV-2-IN-45 (Compound 8p) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-45 inhibits SARS-CoV-2 replication in Calu-3 cell with an EC50 of 0.5 μM, and has no evident cytotoxic effect[1].

• UNSPSC :

  12352005

• Target :

  SARS-CoV

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/sars-cov-2-in-45.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1C2=CC=C(OCOC)C=C2O/C1=C\C3=CC(OCOC)=C(OC)C=C3

• Molecular Formula :

  C20H20O7

• Molecular Weight :

  372.37

• References & Citations :

  [1]Caleffi GS, et al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86 (6) :1536-1549.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported